Paper on Tnk2 published in Cancer Research

In collaboration with Jeff Tyner’s group at the Oregon Health and City University, Portland, the molecular mechanism of Tnk2 activating mutations in leukemia has been investigated. This work was now published in Cancer Research: http://www.ncbi.nlm.nih.gov/pubmed/26677978